Diazoxide-unresponsive congenital hyperinsulinism in children with dominant mutations of the β-cell sulfonylurea receptor SUR1

Courtney M. MacMullen, Qing Zhou, Kara E. Snider, Paul H. Tewson, Susan A. Becker, Ali Rahim Aziz, Arupa Ganguly, Show-Ling Shyng, Charles A. Stanley

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

OBJECTIVE - Congenital hyperinsulinemic hypoglycemia is a group of genetic disorders of insulin secretion most commonly associated with inactivating mutations of the β-cell ATP-sensitive K+ channel (K ATP channel) genes ABCC8 (SUR1) and KCNJ11 (Kir6.2). Recessive mutations of these genes cause hyperinsulinism that is unresponsive to treatment with diazoxide, a channel agonist. Dominant KATP mutations have been associated with diazoxide-responsive disease. We hypothesized that some medically uncontrollable cases with only one KATP mutation might have dominant, diazoxide-unresponsive disease. RESEARCH DESIGN AND METHODS - Mutations of the KATP genes were identified by sequencing genomic DNA. Effects of mutations on KATP channel function in vitro were studied by expression in COSm6 cells. RESULTS - In 15 families with diazoxide-unresponsive diffuse hyperinsulism, we found 17 patients with a monoallelic missense mutation of SUR1. Nine probands had de novo mutations, two had an affected sibling or parent, and four had an asymptomatic carrier parent. Of the 13 different mutations, 12 were novel. Expression of mutations revealed normal trafficking of channels but severely impaired responses to diazoxide or MgADP. Responses were significantly lower compared with nine SUR1 mutations associated with dominant, diazoxide-responsive hyperinsulinism. CONCLUSIONS - These results demonstrate that some dominant mutations of SUR1 can cause diazoxide-unresponsive hyperinsulinism. In vitro expression studies may be helpful in distinguishing such mutations from dominant mutations of SUR1 associated with diazoxide-responsive disease.

Original languageEnglish (US)
Pages (from-to)1797-1804
Number of pages8
JournalDiabetes
Volume60
Issue number6
DOIs
StatePublished - Jun 2011

Fingerprint

Congenital Hyperinsulinism
Sulfonylurea Receptors
Diazoxide
Mutation
Hyperinsulinism
Adenosine Triphosphate
Recessive Genes
KATP Channels
Inborn Genetic Diseases
Missense Mutation

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

MacMullen, C. M., Zhou, Q., Snider, K. E., Tewson, P. H., Becker, S. A., Aziz, A. R., ... Stanley, C. A. (2011). Diazoxide-unresponsive congenital hyperinsulinism in children with dominant mutations of the β-cell sulfonylurea receptor SUR1. Diabetes, 60(6), 1797-1804. https://doi.org/10.2337/db10-1631

Diazoxide-unresponsive congenital hyperinsulinism in children with dominant mutations of the β-cell sulfonylurea receptor SUR1. / MacMullen, Courtney M.; Zhou, Qing; Snider, Kara E.; Tewson, Paul H.; Becker, Susan A.; Aziz, Ali Rahim; Ganguly, Arupa; Shyng, Show-Ling; Stanley, Charles A.

In: Diabetes, Vol. 60, No. 6, 06.2011, p. 1797-1804.

Research output: Contribution to journalArticle

MacMullen, CM, Zhou, Q, Snider, KE, Tewson, PH, Becker, SA, Aziz, AR, Ganguly, A, Shyng, S-L & Stanley, CA 2011, 'Diazoxide-unresponsive congenital hyperinsulinism in children with dominant mutations of the β-cell sulfonylurea receptor SUR1', Diabetes, vol. 60, no. 6, pp. 1797-1804. https://doi.org/10.2337/db10-1631
MacMullen, Courtney M. ; Zhou, Qing ; Snider, Kara E. ; Tewson, Paul H. ; Becker, Susan A. ; Aziz, Ali Rahim ; Ganguly, Arupa ; Shyng, Show-Ling ; Stanley, Charles A. / Diazoxide-unresponsive congenital hyperinsulinism in children with dominant mutations of the β-cell sulfonylurea receptor SUR1. In: Diabetes. 2011 ; Vol. 60, No. 6. pp. 1797-1804.
@article{7420fadedf4d4566b8f3c1c1f18fd124,
title = "Diazoxide-unresponsive congenital hyperinsulinism in children with dominant mutations of the β-cell sulfonylurea receptor SUR1",
abstract = "OBJECTIVE - Congenital hyperinsulinemic hypoglycemia is a group of genetic disorders of insulin secretion most commonly associated with inactivating mutations of the β-cell ATP-sensitive K+ channel (K ATP channel) genes ABCC8 (SUR1) and KCNJ11 (Kir6.2). Recessive mutations of these genes cause hyperinsulinism that is unresponsive to treatment with diazoxide, a channel agonist. Dominant KATP mutations have been associated with diazoxide-responsive disease. We hypothesized that some medically uncontrollable cases with only one KATP mutation might have dominant, diazoxide-unresponsive disease. RESEARCH DESIGN AND METHODS - Mutations of the KATP genes were identified by sequencing genomic DNA. Effects of mutations on KATP channel function in vitro were studied by expression in COSm6 cells. RESULTS - In 15 families with diazoxide-unresponsive diffuse hyperinsulism, we found 17 patients with a monoallelic missense mutation of SUR1. Nine probands had de novo mutations, two had an affected sibling or parent, and four had an asymptomatic carrier parent. Of the 13 different mutations, 12 were novel. Expression of mutations revealed normal trafficking of channels but severely impaired responses to diazoxide or MgADP. Responses were significantly lower compared with nine SUR1 mutations associated with dominant, diazoxide-responsive hyperinsulinism. CONCLUSIONS - These results demonstrate that some dominant mutations of SUR1 can cause diazoxide-unresponsive hyperinsulinism. In vitro expression studies may be helpful in distinguishing such mutations from dominant mutations of SUR1 associated with diazoxide-responsive disease.",
author = "MacMullen, {Courtney M.} and Qing Zhou and Snider, {Kara E.} and Tewson, {Paul H.} and Becker, {Susan A.} and Aziz, {Ali Rahim} and Arupa Ganguly and Show-Ling Shyng and Stanley, {Charles A.}",
year = "2011",
month = "6",
doi = "10.2337/db10-1631",
language = "English (US)",
volume = "60",
pages = "1797--1804",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "6",

}

TY - JOUR

T1 - Diazoxide-unresponsive congenital hyperinsulinism in children with dominant mutations of the β-cell sulfonylurea receptor SUR1

AU - MacMullen, Courtney M.

AU - Zhou, Qing

AU - Snider, Kara E.

AU - Tewson, Paul H.

AU - Becker, Susan A.

AU - Aziz, Ali Rahim

AU - Ganguly, Arupa

AU - Shyng, Show-Ling

AU - Stanley, Charles A.

PY - 2011/6

Y1 - 2011/6

N2 - OBJECTIVE - Congenital hyperinsulinemic hypoglycemia is a group of genetic disorders of insulin secretion most commonly associated with inactivating mutations of the β-cell ATP-sensitive K+ channel (K ATP channel) genes ABCC8 (SUR1) and KCNJ11 (Kir6.2). Recessive mutations of these genes cause hyperinsulinism that is unresponsive to treatment with diazoxide, a channel agonist. Dominant KATP mutations have been associated with diazoxide-responsive disease. We hypothesized that some medically uncontrollable cases with only one KATP mutation might have dominant, diazoxide-unresponsive disease. RESEARCH DESIGN AND METHODS - Mutations of the KATP genes were identified by sequencing genomic DNA. Effects of mutations on KATP channel function in vitro were studied by expression in COSm6 cells. RESULTS - In 15 families with diazoxide-unresponsive diffuse hyperinsulism, we found 17 patients with a monoallelic missense mutation of SUR1. Nine probands had de novo mutations, two had an affected sibling or parent, and four had an asymptomatic carrier parent. Of the 13 different mutations, 12 were novel. Expression of mutations revealed normal trafficking of channels but severely impaired responses to diazoxide or MgADP. Responses were significantly lower compared with nine SUR1 mutations associated with dominant, diazoxide-responsive hyperinsulinism. CONCLUSIONS - These results demonstrate that some dominant mutations of SUR1 can cause diazoxide-unresponsive hyperinsulinism. In vitro expression studies may be helpful in distinguishing such mutations from dominant mutations of SUR1 associated with diazoxide-responsive disease.

AB - OBJECTIVE - Congenital hyperinsulinemic hypoglycemia is a group of genetic disorders of insulin secretion most commonly associated with inactivating mutations of the β-cell ATP-sensitive K+ channel (K ATP channel) genes ABCC8 (SUR1) and KCNJ11 (Kir6.2). Recessive mutations of these genes cause hyperinsulinism that is unresponsive to treatment with diazoxide, a channel agonist. Dominant KATP mutations have been associated with diazoxide-responsive disease. We hypothesized that some medically uncontrollable cases with only one KATP mutation might have dominant, diazoxide-unresponsive disease. RESEARCH DESIGN AND METHODS - Mutations of the KATP genes were identified by sequencing genomic DNA. Effects of mutations on KATP channel function in vitro were studied by expression in COSm6 cells. RESULTS - In 15 families with diazoxide-unresponsive diffuse hyperinsulism, we found 17 patients with a monoallelic missense mutation of SUR1. Nine probands had de novo mutations, two had an affected sibling or parent, and four had an asymptomatic carrier parent. Of the 13 different mutations, 12 were novel. Expression of mutations revealed normal trafficking of channels but severely impaired responses to diazoxide or MgADP. Responses were significantly lower compared with nine SUR1 mutations associated with dominant, diazoxide-responsive hyperinsulinism. CONCLUSIONS - These results demonstrate that some dominant mutations of SUR1 can cause diazoxide-unresponsive hyperinsulinism. In vitro expression studies may be helpful in distinguishing such mutations from dominant mutations of SUR1 associated with diazoxide-responsive disease.

UR - http://www.scopus.com/inward/record.url?scp=79959407988&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959407988&partnerID=8YFLogxK

U2 - 10.2337/db10-1631

DO - 10.2337/db10-1631

M3 - Article

C2 - 21536946

AN - SCOPUS:79959407988

VL - 60

SP - 1797

EP - 1804

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 6

ER -